Top Story

Type 1 diabetes increases post-CABG mortality risk

April 22, 2015

Patients with type 1 diabetes appear to have twice the risk for death after undergoing CABG than patients without type 1 diabetes, according to recent findings.

Type 2 diabetes confers only a slightly increased post-CABG mortality risk, the researchers wrote.

FDA News

FDA panel recommends label changes for Nesina

April 16, 2015
An FDA advisory panel recommended label changes for the diabetes drug Nesina after results from a cardiovascular outcomes trial revealed an increased risk for heart…
FDA News

FDA panel recommends new safety labeling for Onglyza

April 15, 2015
An FDA advisory panel recommended label changes for the diabetes drug Onglyza after results from a cardiovascular outcomes trial revealed an increased risk for heart…
Meeting News Coverage

Glycemic control may improve clopidogrel response in patients with stable CAD

April 10, 2015
SAN DIEGO — In patients with stable CAD, high levels of plasma glucose reduced clopidogrel efficacy, according to data presented at the American College of…
CME
Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent, yet modifiable, risk factor for atherosclerotic disease, pancreatitis, and…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

More »
In the Journals

Higher insulin dosage for type 2 diabetes may increase mortality risk

December 10, 2014
Patients with type 2 diabetes taking exogenous insulin could be at increased risk for death from all causes, major adverse cardiovascular events and…
Steven Grover In the Journals

Life expectancy, healthy years likely to diminish with obesity-related diabetes, CVD

December 4, 2014
Obesity could reduce life expectancy by up to 8 years and healthy years of life by up to 19 years due to the effects of type 2 diabetes and…
Philipp Blanke Meeting News Coverage

Mild CAD increased CV event risk in patients with diabetes

December 3, 2014
Patients with diabetes who have even mild coronary artery disease are as likely to experience a cardiovascular event as those with serious…
Joseph Muhlestein, MD Meeting News CoveragePerspective

FACTOR-64: CCTA screening for CAD failed to reduce 4-year events in diabetes patients

November 17, 2014
CHICAGO — Screening for CAD by coronary computed tomography angiography did not reduce the composite rate of all-cause mortality, nonfatal MI…
Mohammed Ali In the Journals

'Cascade-of-care' displays gaps in US diabetes diagnosis, treatment

November 17, 2014
Using a cascade model to visualize the gaps in awareness of diabetes diagnosis, engagement in care and treatment in the United States, researchers…
Meeting News Coverage

DCB shows promise in femoropopliteal arterial disease, diabetes

November 6, 2014
A drug-coated balloon was safe and effective at 12 months in patients with femoropopliteal arterial disease and diabetes, according to findings…
Healio CMHC2014 Ferdinand2 th Meeting News CoverageVideo

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014
BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of…
thumbnail for video 3857626096001 Meeting News CoverageVideo

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed primarily at diabetes or…
Keith C. Ferdinand Meeting News Coverage

Cardiometabolic Health Congress highlights latest research on CVD, diabetes, obesity

October 23, 2014
BOSTON — The latest innovative research in diabetes, hypertension, lipids, obesity and thrombosis was analyzed by experts at the…
In the Journals

Atherosclerosis risk increased among men with diabetes, low testosterone

October 17, 2014
A greater risk for developing atherosclerosis is found among middle-aged men with low testosterone and type 2 diabetes, according to recent study…
More Headlines »
morganatic-roan